- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03009591
Fascial Therapy in Elbow Hemophilic Arthropathy (HeL-Fascial)
Prospective and Multicenter Study to Assess the Safety and Effectiveness of a Physiotherapy Treatment Through Fascial Therapy in Hemophilic Elbow Arthropathy. A Pilot Study.
Introduction: The common clinical manifestations of hemophilia are skeletal muscle bleeds, especially hematomas and hemarthrosis. Repeated episodes of joint bleeding in certain joints, causing a progressive joint deterioration. Secondary disorders to this joint degeneration include: biomechanical alterations, loss of range of movement and periarticular muscle atrophy.
Design. A prospective, multicenter and longitudinal pilot study to evaluate the efficacy of a treatment protocol with fascial therapy applied in patients with hemophilic arthropathy of the elbow.
Aimed: To evaluate the safety and efficacy of a physiotherapy treatment by fascial therapy in patients with hemophilic arthropathy of the elbow Patients: A total of 60 patients with hemophilia and prophylactic treatment will be recruited for inclusion in the study. Patients will be recruited in 6 centers, from different regions of Spain.
Intervention: Each session will last approximately 50 minutes, with three physiotherapy sessions taking place over a period of 3 weeks. The treatment program includes 11 maneuvers that must be administered bilaterally:
Measuring instruments and study variables: goniometric evaluation (range of movement); visual analog scale (joint pain); Haemophilia Joint Health Score (joint status); DASH Questionnaire (functionality of upper limbs); SF-36 Questionnaire (perception of quality of life). At the same time, the study will allow to determine joint bleeding caused by applied physiotherapy treatment.
Expected results: First, it is intended to demonstrate the safety of this physiotherapy technique in patients with hemophilia. Likewise, an improvement in the perception of elbow pain and joint mobility is expected. An improved functionality of the upper limb is also foreseen and with it, an enhanced perception of quality of life of these patients.
Przegląd badań
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Madird
-
Madrid, Madird, Hiszpania, 28029
- Royal Victoria Eugenia Foundation
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Patients diagnosed with hemophilia A and B
- Patients adults (over 18 years)
- Patients diagnosed with hemophilic arthropathy of the elbow (by clinical assessment with the Hemophilia Joint Health Score)
- Patients pn prophylactic treatment with FVIII / FIX concentrates.
Exclusion Criteria:
- Patients without ambulation ability
- Patients with inhibitors
- Patients with neurological or cognitive alterations that impede the comprehension of the questionnaires and physical tests
- Patients who have not signed the informed consent document.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Zadanie krzyżowe
- Maskowanie: Pojedynczy
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Expermiental group
All patients included in the experimental group should be on prophylactic treatment with FVIII / FIX concentrates.
Likewise, the factor should be administered on the same day that they receive each of the fascial therapy treatment sessions.
Each session will last approximately 50 minutes, with three physiotherapy sessions taking place over a period of 3 weeks.
The treatment program includes 11 maneuvers that must be administered bilaterally:
|
Longitudinal surface sliding maneuver over the superficial fascia in the anterior region of the arm and the forearm. Applied in 3 strokes.
Inne nazwy:
|
Brak interwencji: Control group
Subjects included in the control group will not receive physical therapy through fascial therapy and will continue with their usual routine of physical activity and exercise, and with the same pharmacological treatment regimen with FVIII / FIX.
At the end of the study period the intervention will be applied under the same conditions as the experimental group, analyzing the overall sample at the end of the study.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change from baseline elbow joint bleeding frequency after treatment and at 3 months
Ramy czasowe: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
After the first session of physiotherapy patients will be given a self-register where they can record all the observations they feel (from hematomas or hemarthros, to any other discomfort or perception).
Similarly, the principal investigator of the study will monitor all patients within 48 hours after each physical therapy session.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Change from baseline range of motion of elbow after treatment and at 3 months
Ramy czasowe: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from range of movement of elbow during treatment and follow-up period at 3 months. The range of motion of the elbow joint will be measured using a universal goniometer, using the protocol for measuring joint motion described by Felipe Querol. Measurement instrument: universal goniometer with the protocol to measurement for patients with hemophilia |
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline elbow joint status after treatment and at 3 months
Ramy czasowe: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from elbow joint status during treatment and follow-up period at 3 months.
Measurement instrument: Haemophilia Joint Health Score (scale 0-20).
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline joint pain of elbow after treatment and at 3 months
Ramy czasowe: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from joint pain of ankle during treatment and follow-up period at 3 months.The perception of ankle pain will be measured using visual analog scale (scale 0-10).
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline upper limb functionality after treatment and at 3 months
Ramy czasowe: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from upper limb functionality during treatment and follow-up period at 3 months.
The perception of ankle pain will be measured using DASH Questionnaire.
The Spanish version of this scale used internationally will evaluate upper limb functionality.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from baseline quality of life after treatment and at 3 months
Ramy czasowe: Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Change from quality of life during treatment and follow-up period at 3 months.
The quality of life perception will be measured using SF-36 Questionnaire.
This scale will assess the perception of quality of life of patients included in the study.
|
Screening visit, within the first seven days after treatment and after three months follow-up visit
|
Współpracownicy i badacze
Sponsor
Publikacje i pomocne linki
Publikacje ogólne
- Cuesta-Barriuso R, Meroño-Gallut J, Donoso-Úbeda E, López-Pina JA, Pérez-Llanes R. Effect of a Fascial Therapy Treatment on Quality of Life in Patients With Hemophilic Elbow Arthropathy: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2022 May;103(5):867-874. doi: 10.1016/j.apmr.2021.12.023. Epub 2022 Jan 23.
- Cuesta-Barriuso R, Perez-Llanes R, Lopez-Pina JA, Donoso-Ubeda E, Merono-Gallut J. Manual therapy reduces the frequency of clinical hemarthrosis and improves range of motion and perceived disability in patients with hemophilic elbow arthropathy. A randomized, single-blind, clinical trial. Disabil Rehabil. 2022 Jul;44(15):3938-3945. doi: 10.1080/09638288.2021.1894607. Epub 2021 Mar 8.
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- HeL-Fascial
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
produkt wyprodukowany i wyeksportowany z USA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Experimental group
-
Karadeniz Technical UniversityZakończonyHemodializa | Samotność | Szczęście | Dostosowanie | Terapia wspomagana przez zwierzęta | ObjawIndyk
-
Children's National Research InstituteZakończonySzkolenie w zakresie bezpieczeństwa fotelików samochodowych dla dzieciStany Zjednoczone
-
Aarhus University HospitalUniversity of AarhusZakończonyKobieta z rakiem piersi | Strach przed nawrotem rakaDania
-
Arizona Oncology ServicesNieznanyZlokalizowany rak piersi | Zlokalizowany rak prostaty | Pacjenci otrzymujący radioterapię wiązką zewnętrznąStany Zjednoczone
-
KK Women's and Children's HospitalSingapore Institute for Clinical Sciences; Duke-NUS Graduate Medical SchoolRekrutacyjnyZaburzenia metabolizmu glukozy | Cukrzyca ciężarnych | Choroba metabolicznaSingapur
-
Universitat Jaume IZakończonyZaburzenia depresyjne | Zaburzenia lękoweHiszpania
-
Seyda Ersahan, DDS, PhDAktywny, nie rekrutującyWierzchołkowe zapalenie przyzębia | Uszkodzenie okołowierzchołkoweIndyk
-
University of BurgundyZakończony
-
Universidad Católica San Antonio de MurciaZakończonyBól szyi | Ból punktu spustowego, mięśniowo-powięziowyHiszpania
-
Boston Medical CenterBoston University; National Institute of Diabetes and Digestive and Kidney Diseases... i inni współpracownicyZakończony